4/5Cannabis Bioscience International Holdings, Inc. (CBIH): Late quarterly report (NT 10-Q)

Market data

Price before filing: $0.0006 (2025-04-11 close, split/dividend-adjusted)
Market cap at flag: $6,966 (2025-04-14) · Latest: $1.7M (2026-10-16)

What happened next

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: no open-market insider sales or purchases reported.
30 days after: none reported.

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-01-14 to 2025-05-14. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"The financial information to be contained in the Registrant's Quarterly Report on Form 10-Q for the quarter ended February 28, 2025, cannot be analyzed and completed on a timely basis."

Quoted from the filing. Source

What this means

The company told the SEC it could not file its quarterly report on time (Form NT 10-Q) and then missed the 5-day extension too. Repeated late filings are a stronger warning.

Status: filed late (report filed 2025-04-22)

Why this score: filed late on 2025-04-22; also within 90 days: Going-concern doubt